Sökresultat

Researchers from Lund University Diabetes Centre (LUDC) receive 5,3 million SEK in grants from the Crafoord Foundation in southern Sweden. This year, 15 researchers from LUDC are awarded grants for a wide range of projects in diabetes research. In total, researchers at LUDC receive 5,3 million SEK in grants from the foundation. – It is great news and an important contribution to support projects s

https://www.ludc.lu.se/article/15-researchers-lund-university-diabetes-centre-receive-millions-funding - 2025-10-27

Type 2 diabetes is a complex disease that can lead to serious health problems. It is important to find ways to predict the disease to take preventive measures. A large interdisciplinary study led by Lund University has identified a biomarker in the blood that predicts type 2 diabetes several years before diagnosis. Diabetes is on the rise and over time, diabetes can lead to complications such as c

https://www.ludc.lu.se/article/blood-biomarker-identified-predicts-type-2-diabetes-several-years-diagnosis - 2025-10-27

Diabetes researchers have established methods for screening people with an increased risk of developing type 1 diabetes. Current methods require multiple blood samples during each visit. An international team of researchers has developed a simplified screening method, which will increase screening efficiency. Type 1 diabetes is a disease that requires lifelong treatment with insulin. People of all

https://www.ludc.lu.se/article/improved-screening-efficiency-type-1-diabetes-simplified-blood-draw - 2025-10-27

Three researchers at Lund University Diabetes Centre (LUDC) receive generous grants from the Hjelt Diabetes Foundation in 2021. Ola Hansson, Karl Bacos and Malin Fex have been awarded 45 000 euros each for their research projects. A common aim is to develop a better understanding of the mechanisms behind type 2 diabetes. Diabetes has become a major health issue with nearly half a billion people li

https://www.ludc.lu.se/article/hjelt-foundation-grants-mechanistic-studies-type-2-diabetes - 2025-10-27

Metformin is often described as the first-line medication for the treatment of type 2 diabetes. However, not all patients respond to the drug. Researchers at Lund University have discovered a combination of biomarkers that can predict which patients will benefit from the treatment. This work is now continuing in order to confirm the results in a larger patient group, with the intention of developi

https://www.ludc.lu.se/article/diabetes-research-collaboration-can-pave-way-innovation - 2025-10-27

Emily Sonestedt investigates how food affects the health and the risk to develop type 2 diabetes. This knowledge is of importance to society when developing food-based dietary guidelines. It can be hard to make healthy food choices. The bread rolls behind the counter in the café at Clinical Research Centre (CRC) in Malmö have a dark color, but it does not have to mean that they are a healthy choic

https://www.ludc.lu.se/article/healthy-eating-reduce-risk-type-2-diabetes - 2025-10-27

Identical twins share the same DNA, but one twin may suffer from type 2 diabetes while the other twin does not develop the disease. A study led by Lund University in Sweden has now discovered that there are differences in gene activity in twins where only one sibling had developed the disease. The researchers’ discovery could contribute to the development of new treatment methods. “Identical twins

https://www.ludc.lu.se/article/twin-study-finds-type-2-diabetes-clues-epigenetic-changes - 2025-10-27

Charlotte Ling, a professor of epigenetics and diabetes at Lund University, has been awarded a distinguished professor grant in medicine and health by the Swedish Research Council.  The grant of 50 million SEK over a period of ten years will allow Charlotte Ling to develop the research environment within epigenetics and diabetes at Lund University Diabetes Centre (LUDC).  “I am very grateful for t

https://www.ludc.lu.se/article/distinguished-professor-grant-researcher-epigenetics-and-diabetes - 2025-10-27

A lot of research explains which diets may reduce the risk of developing type 2 diabetes. Much research remains to be done about how our genes respond to the foods we eat. A new study led by researchers at Lund University adds to evidence that variations in the AMY1 gene may affect the way the body breaks down starchy foods. Unhealthy food habits are risk factors for developing type 2 diabetes. An

https://www.ludc.lu.se/article/bread-study-examines-role-genes-breaking-down-food - 2025-10-27

Previous research from Lund University has shown that diabetes can be divided into five groups with different disease progression. A new study published in Nature Genetics demonstrates that there are also genetic differences between different groups of patients. An important goal of the research is to contribute with knowledge that will enable tailored treatments of patients with type 2 diabetes.

https://www.ludc.lu.se/article/new-research-highlights-genetic-differences-between-different-forms-type-2-diabetes - 2025-10-27

The fourth Swedish diabetes summit will be held as an online meeting on the 10th and 11th of February. The meeting brings together diabetes researchers in Sweden for new interactions and collaborations. “We aim to create an inspiring meeting where diabetes researchers can interact and form new collaborations,” says Hindrik Mulder, professor of metabolism at Lund University and chair of the organis

https://www.ludc.lu.se/article/swedish-diabetes-summit-brings-together-diabetes-researchers-new-collaborations - 2025-10-27

Myriam Aouadi is awarded the Leif C. Groop award for her research on the mechanisms behind the development of nonalcoholic fatty liver disease in obese individuals with type 2 diabetes. The prize is awarded annually by Lund University Diabetes Centre to a younger investigator for scientific excellence that will benefit patients suffering from diabetes. Prize motivation: Myriam Aouadi at Karolinska

https://www.ludc.lu.se/article/myriam-aouadi-receives-leif-c-groop-award-outstanding-diabetes-research - 2025-10-27

Food impacts not only the body but also the brain. Researchers at Lund University strive to understand how a diet rich on fat and sugar impacts memory functions in relation to obesity and type 2 diabetes. Their new study on mice shows that although an unhealthy diet leads to memory impairment, the damage does not have to be permanent. Obesity is a risk factor for developing type 2 diabetes and car

https://www.ludc.lu.se/article/diet-rich-fat-and-sugar-damaged-memory-mice-not-permanently - 2025-10-27

People with increased risk of type 2 diabetes need to exercise more than others to achieve the same results, according to new research from Lund University in Sweden. The cause of type 2 diabetes is linked to both genetics and lifestyle. If you have an immediate relative (mother, father, sibling) with type 2 diabetes, the risk of contracting the diabetes is about three times higher. Preventive tre

https://www.ludc.lu.se/article/exercise-good-everyone-some-struggle-more-others - 2025-10-27

Using the CRISPR/Cas9 “gene scissors” researchers at Lund University Diabetes Centre in Sweden have managed to “turn off” an enzyme that proved to play a key role in the regulation of the diabetes-associated TXNIP gene. The results are decreased cell death and increased insulin production in the genetically modified pancreatic beta cells. In a recent study, researchers have conducted an investigat

https://www.ludc.lu.se/article/decreased-cell-death-and-increased-insulin-production-pancreatic-beta-cells-genome-edit-crisprcas9 - 2025-10-27

Charlotte Ling, professor of epigenetics at the Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden, has been awarded the European Research Council’s Consolidator Grant. The funding of EUR 2 million over five years will be used to develop new methods to improve prediction, prevention and treatment of type 2 diabetes. Charlotte Ling is a pioneer within epigenetics and

https://www.ludc.lu.se/article/investments-epigenetics-combat-diabetes - 2025-10-27

BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-year project (total budget 28.9

https://www.ludc.lu.se/article/beat-dkd-innovative-medicines-initiative-project-precision-medicine-dkd - 2025-10-27

In his research in zebrafish, Olov Andersson of Karolinska Institutet strives to generate insulin-producing cells and new treatment methods for diabetes. This has led to his selection as a recipient of the Leif C. Groop award for outstanding research, awarded by the Lund University Diabetes Centre and sponsored by Novo Nordisk Sweden. “It is terrific for our research to be recognised in this way,

https://www.ludc.lu.se/article/prize-awarded-research-zebrafish-could-lead-new-treatments-diabetes - 2025-10-27

A two-days seminar gathered some 70 researchers from the University of Bergen, the Institute for Molecular Medicine in Finland (FIMM) and Lund University Diabetes Centre. - We wanted to strengthen the bonds that already exist and in the future create a Nordic network of metabolic researchers, says Ola Hansson who organized the meeting. Kay Prüfer from Max-Planck Institute in Leipzig, Germany, was

https://www.ludc.lu.se/article/nordic-network-metabolic-researchers - 2025-10-27

In Skåne, newborn babies can be screened for type 1 diabetes and celiac disease (gluten intolerance). To raise awareness about the screening we will be running an information campain on all commuter trains and busses in Skåne during week 15 and 19. Children found to be at risk are eligable to participate in our prevention studies POInT or PreCiSe.More informationPI: Helena Elding Larsson

https://www.ludc.lu.se/article/screening-t1d-and-celiac-disease - 2025-10-27